Global Markets Direct’s pharmaceuticals report, “DiaMedica Inc. - Product Pipeline Review - 2013” provides data on the DiaMedica Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, DiaMedica Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from DiaMedica Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.
- DiaMedica Inc. - Brief DiaMedica Inc. overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of DiaMedica Inc. human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. - Product profiles for late stage and clinical stage products of DiaMedica Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent updates of the DiaMedica Inc.’s pipeline in the last quarter. - Key discontinued and dormant projects. - Latest news and deals relating to the products.
Reasons to buy
- Evaluate DiaMedica Inc.’s strategic position with total access to detailed information on its product pipeline. - Assess the growth potential of DiaMedica Inc. in its therapy areas of focus. - Identify new drug targets and therapeutic classes in the DiaMedica Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. - Exploit collaboration and partnership opportunities with DiaMedica Inc.. - Avoid Intellectual Property Rights related issues. - Explore the dormant and discontinued projects of DiaMedica Inc. and identify potential opportunities in those areas.
Table Of Contents
DiaMedica Inc. - Product Pipeline Review - 2013 Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 DiaMedica Inc. Snapshot 5 DiaMedica Inc. Overview 5 Key Information 5 Key Facts 5 DiaMedica Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 DiaMedica Inc. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 DiaMedica Inc. - Pipeline Products Glance 11 DiaMedica Inc. Clinical Stage Pipeline Products 11 Phase II Products/Combination Treatment Modalities 11 Phase I Products/Combination Treatment Modalities 12 DiaMedica Inc. - Early Stage Pipeline Products 13 Preclinical Products/Combination Treatment Modalities 13 Discovery Products/Combination Treatment Modalities 14 DiaMedica Inc. - Drug Profiles 15 deferoxamine 15 Product Description 15 Mechanism of Action 15 RandD Progress 15 DM-199 16 Product Description 16 Mechanism of Action 16 RandD Progress 16 DM-204 17 Product Description 17 Mechanism of Action 17 RandD Progress 17 DM-365 18 Product Description 18 Mechanism of Action 18 RandD Progress 18 DM-433 19 Product Description 19 Mechanism of Action 19 RandD Progress 19 DM-711 20 Product Description 20 Mechanism of Action 20 RandD Progress 20 DM-99 21 Product Description 21 Mechanism of Action 21 RandD Progress 21 SAN-18 22 Product Description 22 Mechanism of Action 22 RandD Progress 22 DiaMedica Inc. - Pipeline Analysis 23 DiaMedica Inc. - Pipeline Products by Therapeutic Class 23 DiaMedica Inc. - Pipeline Products By Target 25 DiaMedica Inc. - Pipeline Products by Route of Administration 26 DiaMedica Inc. - Pipeline Products By Mechanism of Action 27 DiaMedica Inc. - Recent Pipeline Updates 29 DiaMedica Inc. - Dormant Projects 33 DiaMedica Inc. - Locations And Subsidiaries 34 Head Office 34 Other Locations and Subsidiaries 34 Appendix 35 Methodology 35 Coverage 35 Secondary Research 35 Primary Research 35 Expert Panel Validation 35 Contact Us 36 Disclaimer 36
List of Tables
DiaMedica Inc., Key Information 5 DiaMedica Inc., Key Facts 5 DiaMedica Inc. - Pipeline by Indication, 2013 8 DiaMedica Inc. - Pipeline by Stage of Development, 2013 9 DiaMedica Inc. - Monotherapy Products in Pipeline, 2013 10 DiaMedica Inc. - Phase II, 2013 11 DiaMedica Inc. - Phase I, 2013 12 DiaMedica Inc. - Preclinical, 2013 13 DiaMedica Inc. - Discovery, 2013 14 DiaMedica Inc. - Pipeline By Therapeutic Class, 2013 24 DiaMedica Inc. - Pipeline By Target, 2013 25 DiaMedica Inc. - Pipeline By Route of Administration, 2013 26 DiaMedica Inc. - Pipeline Products By Mechanism of Action, 2013 28 DiaMedica Inc. - Recent Pipeline Updates, 2013 29 DiaMedica Inc. - Dormant Developmental Projects,2013 33 DiaMedica Inc., Other Locations 34
List of Figures
DiaMedica Inc. - Pipeline by Indication, 2013 7 DiaMedica Inc. - Pipeline by Stage of Development, 2013 9 DiaMedica Inc. - Monotherapy Products in Pipeline, 2013 10 DiaMedica Inc. - Pipeline By Therapeutic Class, 2013 23 DiaMedica Inc. - Pipeline By Route of Administration, 2013 26 DiaMedica Inc. - Pipeline Products By Mechanism of Action, 2013 27